Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum
- PMID: 26110780
- DOI: 10.1002/cncr.29524
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum
Abstract
Ovarian, fallopian tube, and peritoneal cancers have a similar clinical presentation and are treated similarly, and current evidence supports staging all 3 cancers in a single system. The primary site (i.e. ovary, fallopian tube, or peritoneum) should be designated where possible. The histologic type should be recorded. Intraoperative rupture ("surgical spill") is IC1; capsule ruptured before surgery or tumor on ovarian or fallopian tube surface is IC2; and positive peritoneal cytology with or without rupture is IC3. The new staging includes a revision of stage III patients; assignment to stage IIIA1 is based on spread to the retroperitoneal lymph nodes without intraperitoneal dissemination. Extension of tumor from omentum to spleen or liver (stage IIIC) should be differentiated from isolated parenchymal metastases (stage IVB).
Keywords: Fallopian tube cancer; ovarian cancer; peritoneal cancer; staging.
© 2015 American Cancer Society.
Comment in
-
Does one size fit all? The updated ovarian cancer staging: Still a work in progress.Cancer. 2015 Oct 1;121(19):3384-6. doi: 10.1002/cncr.29521. Epub 2015 Jun 25. Cancer. 2015. PMID: 26110592 No abstract available.
-
Reply to staging classification for cancer of the ovary and fallopian tube should include in situ carcinoma.Cancer. 2016 Feb 15;122(4):652. doi: 10.1002/cncr.29774. Epub 2015 Nov 4. Cancer. 2016. PMID: 26535793 No abstract available.
-
Staging classification for cancer of the ovary and fallopian tube should include in situ carcinoma.Cancer. 2016 Feb 15;122(4):651. doi: 10.1002/cncr.29776. Epub 2015 Nov 4. Cancer. 2016. PMID: 26535923 No abstract available.
Similar articles
-
Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013.Best Pract Res Clin Obstet Gynaecol. 2015 Aug;29(6):858-69. doi: 10.1016/j.bpobgyn.2015.03.006. Epub 2015 Mar 31. Best Pract Res Clin Obstet Gynaecol. 2015. PMID: 25890882 Review.
-
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878. Int J Gynaecol Obstet. 2021. PMID: 34669199 Free PMC article. Review.
-
Cancer of the ovary, fallopian tube, and peritoneum.Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78. doi: 10.1002/ijgo.12614. Int J Gynaecol Obstet. 2018. PMID: 30306591
-
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.Eur J Obstet Gynecol Reprod Biol. 2015 May;188:133-5. doi: 10.1016/j.ejogrb.2015.03.010. Epub 2015 Mar 7. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 25819291 No abstract available.
-
[New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].Pathologe. 2014 Jul;35(4):322-6. doi: 10.1007/s00292-014-1908-0. Pathologe. 2014. PMID: 24899496 German.
Cited by
-
Clinical Characteristics and Survival of Patients with Malignant Ovarian Tumors in Addis Ababa, Ethiopia.Oncologist. 2019 Jun;24(6):e303-e311. doi: 10.1634/theoncologist.2018-0869. Epub 2019 Apr 25. Oncologist. 2019. PMID: 31023861 Free PMC article.
-
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3286-3302. doi: 10.1007/s00259-021-05450-9. Epub 2021 Jul 3. Eur J Nucl Med Mol Imaging. 2021. PMID: 34215923
-
Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma.J Gynecol Oncol. 2015 Oct;26(4):355-6. doi: 10.3802/jgo.2015.26.4.355. Epub 2015 Sep 23. J Gynecol Oncol. 2015. PMID: 26404127 Free PMC article. No abstract available.
-
Expression of CCL18 gene in ovarian cancer and its impact on the biologic function of ovarian cancer cells.Int J Clin Exp Pathol. 2019 Jul 1;12(7):2572-2584. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934085 Free PMC article.
-
FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii.Front Oncol. 2020 Sep 29;10:584917. doi: 10.3389/fonc.2020.584917. eCollection 2020. Front Oncol. 2020. PMID: 33117719 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical